Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | -32.77%4.03M | -39.65%6M | 128.23%9.94M | 51.64%4.36M | 73.95%2.87M | 16.79%1.65M | 1.41M |
| Revenue from customers | -43.95%1.91M | -54.12%3.42M | 214.47%7.44M | 409.80%2.37M | -71.89%464.3K | 16.79%1.65M | --1.41M |
| Other cash income from operating activities | -18.01%2.12M | 3.40%2.59M | 25.67%2.5M | -17.38%1.99M | --2.41M | ---- | ---- |
| Cash paid | -0.88%-12.43M | -33.66%-12.32M | -13.19%-9.22M | -29.66%-8.15M | -27.07%-6.28M | -36.23%-4.94M | -3.63M |
| Payments to suppliers for goods and services | -0.88%-12.43M | -33.66%-12.32M | -13.19%-9.22M | -29.66%-8.15M | -27.07%-6.28M | -36.23%-4.94M | ---3.63M |
| Direct interest paid | -33.93%-15.98K | -8.76%-11.93K | -9.97%-10.97K | -129.05%-9.97K | -628.09%-4.35K | 21.42%-598 | ---761 |
| Direct interest received | 69.02%576.71K | 185.34%341.21K | 664.52%119.58K | -66.58%15.64K | 26.64%46.8K | --36.95K | ---- |
| Operating cash flow | -30.78%-7.84M | -818.30%-5.99M | 122.06%834.15K | -12.36%-3.78M | -3.40%-3.37M | -46.95%-3.26M | ---2.22M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | 83.34%-50.37K | -61.47%-302.41K | 2.00%-187.29K | -50.19%-191.12K | -127.25K | ||
| Net PPE purchase and sale | 56.24%-50.37K | 38.54%-115.1K | 2.00%-187.29K | -50.19%-191.12K | ---127.25K | ---- | ---- |
| Net intangibles purchas and sale | ---- | ---187.31K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | 83.34%-50.37K | -61.47%-302.41K | 2.00%-187.29K | -50.19%-191.12K | ---127.25K | ---- | ---- |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -101.72%-258.34K | 494.57%15M | 133.04%2.52M | -87.84%1.08M | 107.95%8.9M | -23.29%4.28M | 5.58M |
| Net issuance payments of debt | ---- | ---- | --2.75M | ---- | ---97.67K | ---- | ---- |
| Net common stock issuance | -100.02%-2.38K | 265,836.88%15.25M | -100.46%-5.74K | -86.02%1.26M | 110.23%9M | -23.29%4.28M | --5.58M |
| Net other financing activities | 47.88%-255.96K | -11.02%-491.11K | -26.32%-442.38K | ---350.21K | ---- | ---- | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -101.72%-258.34K | 494.57%15M | 133.04%2.52M | -87.84%1.08M | 107.95%8.9M | -23.29%4.28M | --5.58M |
| Net cash flow | |||||||
| Beginning cash position | 88.00%18.6M | 45.52%9.89M | -29.83%6.8M | 126.36%9.69M | -2.35%4.28M | 330.55%4.38M | --1.02M |
| Current changes in cash | -193.54%-8.14M | 174.68%8.71M | 209.67%3.17M | -153.44%-2.89M | 427.35%5.41M | -69.52%1.03M | --3.37M |
| End cash Position | -43.79%10.46M | 86.59%18.6M | 46.62%9.97M | -29.83%6.8M | 79.14%9.69M | 23.40%5.41M | --4.38M |
| Free cash from | -25.30%-7.89M | -1,073.03%-6.29M | 116.28%646.86K | -13.74%-3.97M | -7.31%-3.49M | -46.95%-3.26M | ---2.22M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |